Following 12 weeks of supplementation, this randomized double blind placebo controlled trial had 98 subjects with high cholesterol. There was a significant decrease in total cholesterol, triglycerides, LDL-cholesterol and VLDL cholesterol levels in the amla supplementation group, compared to the placebo group.
References:
Upadya, H., Prabhu, S., Prasad, A., Subramanian, D., Gupta, S., & Goel, A. (2019). A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia. BMC complementary and alternative medicine, 19(1), 27. https://doi.org/10.1186/s12906-019-2430-y
